Abstract. The poor prognosis of patients with advanced oesophageal cancer is proof of its ability to spread. Locoregional spread is often discontinuous, i.e. distant regional lymph nodes may be invaded even when local nodes are free of tumour. In patients with potentially curable cancer, we advocate subtotal oesophagectomy pio-neered in the UK by McKeown on the grounds that generous proximal clearance gives the best chance of clea-ring satellite nodules in the submucosal lymphatics and gives the best postoperative function with the least ten-dency for gastro-oesophageal reflux. Patients who have an incurable disease should not be submitted to need-lessly aggressive treatment that simply prolongs the process of dying, so the role of palliati...
Palliative therapies in esophageal cancer Esophageal cancer is a lethal malignancy, with a rising i...
textabstractThe prognosis of esophageal cancer is poor with a 5-year survival of 10-15%. In additio...
Background: Oesophageal cancer patients have poor survival, and most are unfit for curative or syste...
Palliative management of patients with incurable oesophageal cancer necessitates a broad spectrum of...
Oesophageal cancer frequently presents late and with incurable disease; therefore, knowledge and exp...
Background: The outcome of different palliative regimens was investigated in patients with incurable...
The 5-year survival rate is only 3% for patients with lymph node involvement, whereas it is 42% for ...
Background: The outcome of different palliative regimens was investigated in patients with incurable...
Cancer of the esophagus is assessed to be the 8th most common cancer form in the world, with approxi...
textabstractApproximately 400,000 patients are annually diagnosed world-wide with esophageal cancer,...
textabstractMany improvements have been made in the treatment of oesophageal cancer. Surgical techn...
Oesophageal cancer is a clinically challenging disease that requires a multidisciplinary approach. E...
This review article aims to discuss the modalities of oesophageal resection, to define the categorie...
Accurate pretherapy staging for esophageal cancer is important for stage-directed therapy. Precise s...
Abstract Oesophageal cancer is a disease of dismal prognosis. There are variations of epidemiology a...
Palliative therapies in esophageal cancer Esophageal cancer is a lethal malignancy, with a rising i...
textabstractThe prognosis of esophageal cancer is poor with a 5-year survival of 10-15%. In additio...
Background: Oesophageal cancer patients have poor survival, and most are unfit for curative or syste...
Palliative management of patients with incurable oesophageal cancer necessitates a broad spectrum of...
Oesophageal cancer frequently presents late and with incurable disease; therefore, knowledge and exp...
Background: The outcome of different palliative regimens was investigated in patients with incurable...
The 5-year survival rate is only 3% for patients with lymph node involvement, whereas it is 42% for ...
Background: The outcome of different palliative regimens was investigated in patients with incurable...
Cancer of the esophagus is assessed to be the 8th most common cancer form in the world, with approxi...
textabstractApproximately 400,000 patients are annually diagnosed world-wide with esophageal cancer,...
textabstractMany improvements have been made in the treatment of oesophageal cancer. Surgical techn...
Oesophageal cancer is a clinically challenging disease that requires a multidisciplinary approach. E...
This review article aims to discuss the modalities of oesophageal resection, to define the categorie...
Accurate pretherapy staging for esophageal cancer is important for stage-directed therapy. Precise s...
Abstract Oesophageal cancer is a disease of dismal prognosis. There are variations of epidemiology a...
Palliative therapies in esophageal cancer Esophageal cancer is a lethal malignancy, with a rising i...
textabstractThe prognosis of esophageal cancer is poor with a 5-year survival of 10-15%. In additio...
Background: Oesophageal cancer patients have poor survival, and most are unfit for curative or syste...